DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹10,123 Cr | ₹9,042 Cr | ₹8,030 Cr | ₹7,249 Cr | ₹6,676 Cr |
What is the latest Sundry Debtors ratio of DR REDDYS LABORATORIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹10,123 Cr |
| Mar2025 | ₹9,042 Cr |
| Mar2024 | ₹8,030 Cr |
| Mar2023 | ₹7,249 Cr |
| Mar2022 | ₹6,676 Cr |
How is Sundry Debtors of DR REDDYS LABORATORIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹10,123 Cr | 11.96 | |
| Mar2025 | ₹9,042 Cr | 12.61 | |
| Mar2024 | ₹8,030 Cr | 10.78 | |
| Mar2023 | ₹7,249 Cr | 8.57 | |
| Mar2022 | ₹6,676 Cr | - | |
Compare Sundry Debtors of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹97,651.6 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| MANKIND PHARMA | ₹102,194.0 Cr | -5.5% | -2.2% | -5.1% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 3% |
-14.9% |
-10.2% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses